PI3-kinase can activate NF-kB signaling through Akt (43); however, it is difficult to clarify whether CEACAM-positive monocytes in SSc have received intracellular signaling through CEACAM in vivo. The gene discussed is NFKB1; the disease is systemic sclerosis.